top of page
Pharmaceuticals - Regulatory Performance
Review Times At a Glance
New Drug Applications
2017
2018
Percentage of Cleared 510(k)s Based on Year Submitted
Data as of 1 July 2019
UNDER CONSTRUCTION
In general, review times ...
2018
510(k) Review Time by Review Committee
All 510(k) Types
What Review Committee?
Review times can vary based on the Review Committee.
​
In both 2017 and 2018, Anesthesiology and Molecular Genetics groups had the highest review times. Radiology, Microbiology, and Ophthalmology had the shortest review times.
De Novo Reviews
Review Times At a Glance
De Novo reviews are generally longer than 510(k)s. Over time, the review times have decreased, but the average is still closer to what we see with original PMAs.
​
Most are submitted directly, although there are still a few that are Post-NSE.
​
Less than half of De Novo submissions logged in are eventually approved. The longer review times mean that we wait longer to really see the success rate.
2016
2017
​2018
Percentage of Approved De Novo Based on Year Submitted
Data as of 1 July 2019
De Novo Review Times by Reviewing Committee
Review times for De Novo submissions can vary greatly between reviewing committees.
​
Note that in 2018, one outlier (DEN070001) in MI, drives their average higher. Without the outlier, MI had an average review time in 2018 of 207 days.
Review Times At a Glance
Premarket Approvals
2016
2017
​2018
Percentage of Approved original PMAs Based on Year Submitted
Data as of 1 July 2019
Average review days for original PMAs increased to 465 days in 2018 from 354 days in 2017.
​
Panel Track Supplement review days also rose in 2018. The rest of supplement types have stayed fairly consistent year over year.
Original PMA Review Times by Advisory Committee 2017 to 2019 YTD
Review times increased for CV, SU, and OR. Reviews in CH, TX and GU were higher than the 2017 average, raising the overall average review time 111 days.
De Novo Review Days Distribution
Say something here
​
​
about this graphic
Reasons for PMA Supplements
Process changes are the most frequent reason for a PMA supplement, followed by a design change.
What other metric would you like to see?
bottom of page